Local Minneapolis Star and Tribune Reporter James Walsh Cracks the need for SEC disclosures from Device Manufacturers in the Myxo File Part III

Jan 31, 2013, 11:08 ET from ConcieValve LLP

CHICAGO, Jan. 31, 2013 /PRNewswire/ - The Myxo File Part I and part II reveals the truth surrounding the Clinical trials testing heart devices between 2003-2009. Soon after Mr. James Walsh published in the Minneapolis Star and Tribune, the full disclosure by St. Jude to investors, he reported:

(Photo: http://photos.prnewswire.com/prnh/20130131/TO530)

"The U.S. Food and Drug Administration has sent a warning letter to St. Jude Medical regarding manufacturing processes at a facility in Southern California, St. Jude and the FDA have confirmed and reported January 14, 2013".

The Myxo File Part III was recently written and published on Kindle Direct Publishing linking the importance of full disclosure by Medical Device Manufacturers and Medical Device Safety for Citizens across the world. Providential Meeting with the President of the United States is described in the Biographical story to make device safety a top issue for US hospitals across the United States.

Nalini M. Rajamannan, MD is the author of the Myxo File Part I, Part II, and Part III, which has published the original documents supporting this release on Amazon and Kindle Direct Publishing, Rajamannan is the CEO of Concie Valve LLC.

SOURCE ConcieValve LLP